Average Co-Inventor Count = 6.14
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Takeda Pharmaceutical Company Limited (12 from 1,179 patents)
2. Nxera Pharma UK Limited (1 from 13 patents)
13 patents:
1. 12234227 - Pyrazole derivatives as H4 antagonist compounds
2. 12186313 - Pyridazinone compounds and their use as DAAO inhibitors
3. 11129828 - Pyridazinone compounds and their use as DAAO inhibitors
4. 10689373 - 1,2-substituted cyclopentanes as orexin receptor antagonists
5. 10463663 - Pyridazinone compounds and their use as DAAO inhibitors
6. 10011588 - 1,2-substituted cyclopentanes as orexin receptor antagonists
7. 9931340 - Pyridazinone compounds and their use as DAAO inhibitors
8. 9790220 - Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists
9. 9750748 - Pyridazinones as DAAO enzyme inhibitors
10. 9493432 - Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders
11. 9290456 - Pyridazinone compounds and their use as DAAO inhibitors
12. 9180122 - 5- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain
13. 9156829 - Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists